Chen Zhi, Li Ming, Zhang Li-Li, Wu De
Department of Pediatrics, First Affiliated Hospital of Anhui Medical University, Hefei 230031, China.
Zhongguo Dang Dai Er Ke Za Zhi. 2024 Oct 15;26(10):1040-1045. doi: 10.7499/j.issn.1008-8830.2405073.
To explore the effects of antenatal corticosteroids (ACS) on the outcomes of very premature infants (VPIs) and neurodevelopment during infancy.
A retrospective study was conducted on 190 VPIs admitted to the Department of Pediatrics of the First Affiliated Hospital of Anhui Medical University from January 2020 to December 2022. The infants were categorized into four groups based on ACS usage and dosage: no ACS group (=18), single-course group (=88), multi-course group (=40), and partial-course group (=44). The clinical outcomes, Neonatal Behavioral and Neurological Assessment (NBNA) scores at 40 weeks of corrected age, and Gesell Developmental Schedule (Gesell) scores at 1 year of corrected age were compared among the four groups. The impact of timing of ACS use on the Gesell scores of infants at 1 year of corrected age in VPIs with specific gestational ages was analyzed.
The incidence rates of neonatal respiratory distress syndrome, bronchopulmonary dysplasia, transient tachypnea of the newborn, and neonatal pneumonia were significantly lower in the partial-course, single-course, and multiple-course groups compared with the no ACS group (<0.008). However, there was no significant difference among the partial-course, single-course, and multiple-course groups (>0.008). The NBNA scores (behavioral ability, active muscle tone, primitive reflexes, and general assessment) at 40 weeks of corrected age were significantly higher in the no ACS, partial-course, and single-course groups than in the multiple-course group (<0.008). The proportion of VPIs with normal neurodevelopment at 1 year of corrected age was significantly higher in the no ACS, partial-course, and single-course groups than in the multiple-course group (<0.008). The timing of ACS use had no significant effect on neurodevelopment at a corrected age of 1 year in infants with various gestational ages (>0.05).
ACS is crucial for the development of the respiratory system in VPIs, but multiple courses of ACS may cause neurodevelopmental abnormalities. The impact of ACS use on neurodevelopment is independent of gestational age and the timing of ACS use.
探讨产前使用糖皮质激素(ACS)对极早产儿(VPI)结局及婴儿期神经发育的影响。
对2020年1月至2022年12月在安徽医科大学第一附属医院儿科收治的190例VPI进行回顾性研究。根据ACS的使用情况和剂量将婴儿分为四组:未使用ACS组(=18)、单疗程组(=88)、多疗程组(=40)和部分疗程组(=44)。比较四组的临床结局、矫正年龄40周时的新生儿行为神经评定(NBNA)评分以及矫正年龄1岁时的格塞尔发育量表(Gesell)评分。分析特定胎龄的VPI中ACS使用时间对矫正年龄1岁婴儿Gesell评分的影响。
部分疗程组、单疗程组和多疗程组新生儿呼吸窘迫综合征、支气管肺发育不良、新生儿短暂性呼吸急促和新生儿肺炎的发生率显著低于未使用ACS组(<0.008)。然而,部分疗程组、单疗程组和多疗程组之间无显著差异(>0.008)。未使用ACS组、部分疗程组和单疗程组矫正年龄40周时的NBNA评分(行为能力、主动肌张力、原始反射和总体评定)显著高于多疗程组(<0.008)。矫正年龄1岁时神经发育正常的VPI比例在未使用ACS组、部分疗程组和单疗程组显著高于多疗程组(<0.008)。ACS使用时间对不同胎龄婴儿矫正年龄1岁时的神经发育无显著影响(>0.05)。
ACS对VPI呼吸系统发育至关重要,但多疗程使用ACS可能导致神经发育异常。ACS使用对神经发育的影响独立于胎龄和ACS使用时间。